Literature DB >> 33925205

Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.

Juan P Rodrigo1,2,3, Mario Sánchez-Canteli1,2,3, Fernando López1,2,3, Gregory T Wolf4, Juan C Hernández-Prera5, Michelle D Williams6, Stefan M Willems7, Alessandro Franchi8, Andrés Coca-Pelaz1,2,3, Alfio Ferlito9.   

Abstract

The presence of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment has been demonstrated to be of prognostic value in various cancers. In this systematic review and meta-analysis, we investigated the prognostic value of TIL in laryngeal squamous cell carcinoma (LSCC). We performed a systematic search in PubMed for publications that investigated the prognostic value of TIL in LSCC. A meta-analysis was performed including all studies assessing the association between TIL counts in hematoxylin-eosin (HE)-stained sections, for CD8+ and/or CD3+/CD4+ TIL and overall survival (OS) or disease-free survival (DFS). The pooled meta-analysis showed a favorable prognostic role for stromal TIL in HE sections for OS (HR 0.57, 95% CI 0.36-0.91, p = 0.02), and for DFS (HR 0.56, 95% CI 0.34-0.94, p = 0.03). High CD8+ TIL were associated with a prolonged OS (HR 0.62, 95% CI 0.4-0.97, p = 0.04) and DFS (HR 0.73, 95% CI 0.34-0.94, p = 0.002). High CD3+/CD4+ TIL demonstrated improved OS (HR 0.32, 95% CI 0.16-0.9, p = 0.03) and DFS (HR 0.23, 95% CI 0.10-0.53, p = 0.0005). This meta-analysis confirmed the favorable prognostic significance of TIL in LSCC. High stromal TIL evaluated in HE sections and intra-tumoral and stromal CD3+, CD4+ and/or CD8+ TIL might predict a better clinical outcome.

Entities:  

Keywords:  larynx; prognosis; squamous cell carcinoma; tumor-infiltrating lymphocytes

Year:  2021        PMID: 33925205     DOI: 10.3390/biomedicines9050486

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  49 in total

1.  The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients.

Authors:  Marc Van den Eynde; Bernhard Mlecnik; Gabriela Bindea; Tessa Fredriksen; Sarah E Church; Lucie Lafontaine; Nacilla Haicheur; Florence Marliot; Mihaela Angelova; Angela Vasaturo; Daniela Bruni; Anne Jouret-Mourin; Pamela Baldin; Nicolas Huyghe; Karin Haustermans; Annelies Debucquoy; Eric Van Cutsem; Jean-Francois Gigot; Catherine Hubert; Alex Kartheuser; Christophe Remue; Daniel Léonard; Viia Valge-Archer; Franck Pagès; Jean-Pascal Machiels; Jérôme Galon
Journal:  Cancer Cell       Date:  2018-12-10       Impact factor: 31.743

2.  Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.

Authors:  Rebecca Hoesli; Andrew C Birkeland; Andrew J Rosko; Mohamad Issa; Kelsey L Chow; Nicole L Michmerhuizen; Jacqueline E Mann; Steven B Chinn; Andrew G Shuman; Mark E Prince; Gregory T Wolf; Carol R Bradford; Jonathan B McHugh; J Chad Brenner; Matthew E Spector
Journal:  Oral Oncol       Date:  2017-12-23       Impact factor: 5.337

3.  Postoperative radiotherapy for laryngeal cancer. The prognostic role of programmed death-ligand 1: An immune microenvironment-based cluster analysis.

Authors:  Leonardo Franz; Lara Alessandrini; Giancarlo Ottaviano; Roberto di Carlo; Elena Fasanaro; Giulia Ramacciotti; Giacomo Contro; Gino Marioni
Journal:  Pathol Res Pract       Date:  2020-07-13       Impact factor: 3.250

4.  The ratio of CD4/CD8 T-cells in human papillomavirus-positive laryngeal squamous cell carcinoma accounts for improved outcome.

Authors:  Duo Zhang; Wei-Jing Tang; Di Tang; Jian Zhou; Liang Chou; Lei Tao; Li-Ming Lu
Journal:  Acta Otolaryngol       Date:  2016-04-15       Impact factor: 1.494

5.  Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression, and tumor immune microenvironment in laryngeal cancer.

Authors:  Leonardo Franz; Lara Alessandrini; Elena Fasanaro; Piergiorgio Gaudioso; Alessandro Carli; Piero Nicolai; Gino Marioni
Journal:  Ann Diagn Pathol       Date:  2020-11-05       Impact factor: 2.090

Review 6.  TILs in Head and Neck Cancer: Ready for Clinical Implementation and Why (Not)?

Authors:  Astrid De Meulenaere; Tijl Vermassen; Sandrine Aspeslagh; Katrien Vandecasteele; Sylvie Rottey; Liesbeth Ferdinande
Journal:  Head Neck Pathol       Date:  2016-12-28

Review 7.  Head and neck squamous cell carcinoma.

Authors:  Daniel E Johnson; Barbara Burtness; C René Leemans; Vivian Wai Yan Lui; Julie E Bauman; Jennifer R Grandis
Journal:  Nat Rev Dis Primers       Date:  2020-11-26       Impact factor: 52.329

8.  Prognostic Impact of Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Patients.

Authors:  Duo Zhang; Di Tang; Yu Heng; Xiao-Ke Zhu; Liang Zhou; Lei Tao; Li-Ming Lu
Journal:  Laryngoscope       Date:  2020-10-27       Impact factor: 3.325

9.  Prognostic Value of Tumor-Infiltrating Lymphocytes in Head and Neck Squamous Cell Carcinoma.

Authors:  Matthew E Spector; Emily Bellile; Lahin Amlani; Katie Zarins; Joshua Smith; J Chad Brenner; Laura Rozek; Ariane Nguyen; Daffyd Thomas; Jonathan B McHugh; Jeremy M G Taylor; Gregory T Wolf
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-11-01       Impact factor: 6.223

Review 10.  The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.

Authors:  Emma J de Ruiter; Marc L Ooft; Lot A Devriese; Stefan M Willems
Journal:  Oncoimmunology       Date:  2017-08-09       Impact factor: 8.110

View more
  3 in total

1.  Immune Cell and Biochemical Biomarkers in Advanced Laryngeal Cancer.

Authors:  Ana Jotic; Jovica Milovanovic; Katarina Savic-Vujovic; Zorana Radin; Branislava Medic; Miljan Folic; Bojan Pavlovic; Aleksandar Vujovic; Dusko Dundjerovic
Journal:  Dose Response       Date:  2022-07-19       Impact factor: 2.623

2.  The Exosomal miR-1246 of Laryngeal Squamous Cell Carcinoma Induces Polarization of M2 Type Macrophages and Promotes the Invasiveness of Laryngeal Squamous Cell Carcinoma.

Authors:  Lifeng Wu; Na Zuo; Shuo Pan; Yue Wang; Qixue Wang; Jun Ma
Journal:  J Oncol       Date:  2022-09-26       Impact factor: 4.501

Review 3.  Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: Ready for Prime Time?

Authors:  Alhadi Almangush; Stijn De Keukeleire; Sylvie Rottey; Liesbeth Ferdinande; Tijl Vermassen; Ilmo Leivo; Antti A Mäkitie
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.